Neurology

Analysis of data from more than 21 000 migraineurs found that less than 1 in 3 take prescribed acute medications and less than 1 in 5 take prescribed preventive agents.

As neurologic findings among patients with COVID-19 emerge, comparison to sequelae seen with other coronaviruses is instructive.

Over half of US adults who responded to a new survey said COVID-19 has impacted their mental health. To what extent? Find out in our new slideshow.

Almost half of Americans are anxious about contracting COVID-19, suggests a new American Psychiatric Association poll. More results at-a-glance here.

Frontline medical workers dealing with COVID-19 in China have a high risk of developing symptoms of depression, anxiety, insomnia, and distress.

Mental illness affects 1 in 5 US adults every year; some of them are your patients. This brief study of "the numbers" is essential.

Two first-in-class migraine drugs, the first generic version of NuvaRing®, and 7 more fourth quarter FDA-approved drugs for primary care.

A new study found a significant association between increased stroke risk and dual use of e-cigarettes and traditional cigarettes-authors urging physicians to use results as a wake-up call.

Highlights from a recent evidence-based review offer guidance on feasible depression treatments in primary care.

The FDA has approved the first oral CGRP receptor antagonist in pill form for the acute treatment of migraine with or without aura in adults.

ICYMI: Get a quick look at 12 of the many drugs FDA-approved in 2019 for conditions commonly seen in primary care.

When a patient presents to their primary care physician with a headache, it's not always diagnosed as the migraine it is. These 6 tips from a neurologist can help.

Highlights of an evidence-based review offer practical guidance for effective depression screening and assessment strategies for primary care physicians.

A new study being presented next week at AHA's 2019 Scientific Sessions found a strong link between depression and non-fatal heart disease. 

Two studies to be presented at the upcoming AHA annual meeting found that young cannabis users are at greater risk for stroke and arrhythmia. 

"Typical aura without headache" is a relatively rare headache diagnosis and not easy to make. Three leading headache specialists offer guidance on how to recognize and treat.

Lasmitidan is the first 5-HT1F receptor agonist to receive FDA approval and was found superior to placebo for reduction of migraine pain and most bothersome symptom at 2 hours.

Children, tweens, and adolescents with migraine can use Migraine Trainer to log and share details that will help physicians individualize care in this vulnerable population.

A new study suggests that deep brain stimulation may be a safe and effective treatment option for patients with treatment-resistant depression. 

Throbbing occipital headache x2 wks; abrupt onset, no history. Reason for alarm? Neurologist Peter McAllister, MD, suggests you SNOOP first.

Veterans who suffer from mental illness were found to be at an increased risk for major cardiovascular disease outcomes in a new study. 

What's your caffeine IQ? Test your knowledge on the latest caffeine research from its effect on cardiovascular disease to liver cancer with this brief quiz. 

Injectable medications for migraine are effective, inexpensive, and easy to store. Try these 5 questions on 5 you may want to have on hand.

Read why one migraine specialist believes that biofeedback should be the first line of treatment in patients with migraine. 

A cup of coffee/day keeps migraine away? It can, but before recommending another cup to migraine patients, review findings just published.